Back to Atlas
BSemi-durableStandard research/education caution
CMP-0167
Research
Antioxidant peptide A (PHCKRM)
Antioxidant / Cytoprotection
Potential radical-scavenging and cytoprotective research activity
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Synthetic peptide
- Primary mechanism
- Cysteine/histidine-containing antioxidant peptide motif
- Primary market use
- Oxidative stress research
Pharmacology
- Molecular weight (Da)
- ~771.0
- Oral bioavailability
- N/A (peptide; not oral)
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Preclinical
- Clinical status
- Research
- Value-for-money score
- 2 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Sequence-based MW estimate for PHCKRM; limited translational data